Social media boosting patient recruitment, but FDA guidance needed

By Gareth Macdonald

- Last updated on GMT

Related tags Contract research organisations Food and drug administration Contract research organization

Social media boosting patient recruitment, but FDA guidance needed
CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed.

Outsourcing-pharma.com spoke with Brian Loew, CEO of Inspire, an online community of over 70 disease-specific patient communities, who explained that the benefits go beyond access to patients.

“It’s not just access to large number of patients, it’s the fact that those patients are deciding in large number to participate in clinical trials.”

Loew went on to explain that this volunteering process helps contract research organisations and pharmas tackle some of the prescreening, selection and permission hurdles that can otherwise hamper recruitment.

However, he added, CROs still face regulatory hurdles when accessing these types of social networks that would benefit from further clarification from regulators.

The FDA could help us all by being clear about what is ok and what is not ok…and the absence of that clarity is making it difficult for industry​.”

Related news

Show more

Related products

show more

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 16-Jan-2023 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

PPD - Decentralized Clinical Trials | 12-Jan-2023 | Technical / White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are...

PPD is Supporting Complex EU DCTs

PPD is Supporting Complex EU DCTs

PPD - Decentralized Clinical Trials | 05-Jan-2023 | Technical / White Paper

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 14-Dec-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars